(a)
the crisis preparedness and management framework for medicinal products and medical devices, including the outcomes of periodic stress tests;
← art_36__para_1__text_1 · All articles · art_36__para_1__point_a__text_1 →
Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.